pLKO.1 - TRC cloning vector Citations (627)
Originally described in: A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen.Moffat J, Grueneberg DA, Yang X, Kim SY, Kloepfer AM, Hinkle G, Piqani B, Eisenhaure TM, Luo B, Grenier JK, Carpenter AE, Foo SY, Stewart SA, Stockwell BR, Hacohen N, Hahn WC, Lander ES, Sabatini DM, Root DE Cell. 2006 Mar 24. 124(6):1283-98. PubMed Journal
Articles Citing pLKO.1 - TRC cloning vector
Showing 1 to 10 of 627 entries
| Articles |
|---|
Articles |
|---|
| Mitochondrial Calcium Signaling Regulates Branched-Chain Amino Acid Catabolism in Fibrolamellar Carcinoma. Marsh NM, MacEwen MJS, Chea J, Kenerson HL, Kwong AA, Locke TM, Miralles FJ, Sapre T, Gozali N, Atilla-Gokcumen GE, Ong SE, Scott JD, Yeung RS, Sancak Y. bioRxiv [Preprint]. 2024 May 28:2024.05.27.596106. doi: 10.1101/2024.05.27.596106. PubMed |
| CPT1A loss disrupts BCAA metabolism to confer therapeutic vulnerability in TP53-mutated liver cancer. Liu Y, Wang F, Yan G, Tong Y, Guo W, Li S, Qian Y, Li Q, Shu Y, Zhang L, Zhang Y, Xia Q. Cancer Lett. 2024 Jul 28;595:217006. doi: 10.1016/j.canlet.2024.217006. Epub 2024 May 31. PubMed |
| Mechanical activation of VE-cadherin stimulates AMPK to increase endothelial cell metabolism and vasodilation. Cronin NM, Dawson LW, DeMali KA. bioRxiv [Preprint]. 2024 May 13:2024.05.09.593171. doi: 10.1101/2024.05.09.593171. PubMed |
| Opportunistic pathogen Porphyromonas gingivalis targets the LC3B-ceramide complex and mediates lethal mitophagy resistance in oral tumors. Sheridan M, Chowdhury N, Wellslager B, Oleinik N, Kassir MF, Lee HG, Engevik M, Peterson Y, Pandruvada S, Szulc ZM, Yilmaz O, Ogretmen B. iScience. 2024 Apr 30;27(6):109860. doi: 10.1016/j.isci.2024.109860. eCollection 2024 Jun 21. PubMed |
| O-GlcNAcylation regulates the stability of transferrin receptor (TFRC) to control the ferroptosis in hepatocellular carcinoma cells. Zhou X, Wang Y, Li X, Zhou J, Yang W, Wang X, Jiao S, Zuo W, You Z, Ying W, Wu C, Bao J. Redox Biol. 2024 Jul;73:103182. doi: 10.1016/j.redox.2024.103182. Epub 2024 May 8. PubMed |
| FBXO22 is a potential therapeutic target for recurrent chondrosarcoma. Xin B, Chen H, Zhu Z, Guan Q, Bai G, Yang C, Zou W, Gao X, Li L, Liu T. J Bone Oncol. 2024 May 1;46:100605. doi: 10.1016/j.jbo.2024.100605. eCollection 2024 Jun. PubMed |
| Long-term expandable mouse and human-induced nephron progenitor cells enable kidney organoid maturation and modeling of plasticity and disease. Huang B, Zeng Z, Kim S, Fausto CC, Koppitch K, Li H, Li Z, Chen X, Guo J, Zhang CC, Ma T, Medina P, Schreiber ME, Xia MW, Vonk AC, Xiang T, Patel T, Li Y, Parvez RK, Der B, Chen JH, Liu Z, Thornton ME, Grubbs BH, Diao Y, Dou Y, Gnedeva K, Ying Q, Pastor-Soler NM, Fei T, Hallows KR, Lindstrom NO, McMahon AP, Li Z. Cell Stem Cell. 2024 Jun 6;31(6):921-939.e17. doi: 10.1016/j.stem.2024.04.002. Epub 2024 Apr 30. PubMed |
| Mitochondria inside acute myeloid leukemia cells hydrolyze ATP to resist chemotherapy. Hagen JT, Montgomery MM, Aruleba RT, Chrest BR, Green TD, Kassai M, Zeczycki TN, Schmidt CA, Bhowmick D, Tan SF, Feith DJ, Chalfant CE, Loughran TP Jr, Liles D, Minden MD, Schimmer AD, Cabot MC, Mclung JM, Fisher-Wellman KH. bioRxiv [Preprint]. 2024 Apr 15:2024.04.12.589110. doi: 10.1101/2024.04.12.589110. PubMed |
| Tumor‑suppressive effects of Smad‑ubiquitination regulator 2 in papillary thyroid carcinoma. Luo G, Zhang L, Zhang L, Wu W, Lin J, Shi H, Yu Y, Qiu W, Chen J, Ding H, Chen X. Oncol Lett. 2024 Apr 10;27(6):263. doi: 10.3892/ol.2024.14396. eCollection 2024 Jun. PubMed |
| Influenza A virus NS1 effector domain is required for PA-X-mediated host shutoff in infected cells. Bougon J, Kadijk E, Gallot-Lavallee L, Curtis BA, Landers M, Archibald JM, Khaperskyy DA. J Virol. 2024 May 14;98(5):e0190123. doi: 10.1128/jvi.01901-23. Epub 2024 Apr 17. PubMed |
If you have published an article using this material, please email us at help@addgene.org to have your article added to this page.